NCT00743496: A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma |
|
|
| Completed | 1 | 50 | US | Anti-GD2 antibody | St. Jude Children's Research Hospital, Evan T.J. Dunbar Neuroblastoma Foundation, Duke University, University of Wisconsin, Madison, University Children's Hospital Tuebingen, Children's Hospital Los Angeles | Neuroblastoma, Melanoma, Osteosarcoma, Ewing Sarcoma | 04/14 | 04/14 | | |
